DB17667InvestigationalProtein Based Therapies
SYNB1020 is an engineered strain of Escherichia coli Nissle 1917 developed by Synlogic Inc. It was initially designed to convert ammonia to L-arginine and granted orphan designation by the FDA...
- Code names
- SYNB1020
What you can answer from here — as of April 23, 2025
Which companies are running trials of SYNB1020, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account